New hope for Tough-to-Treat lung cancer patients
NCT ID NCT07203053
Summary
This study is testing an experimental drug called tarlatamab for people with an aggressive form of lung cancer that has worsened after their first round of chemotherapy and immunotherapy. It aims to see if the drug can help patients live longer and control the cancer. The trial will involve 48 participants who are in relatively poorer health and have few other treatment options.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for EXTENSIVE STAGE LUNG SMALL CELL CANCER are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
AO San Giovanni Addolorata
Roma, Italy
Contact
-
CHU Angers
Angers, France
Contact
-
Geneva University Hospitals
Geneva, Switzerland
Contact
-
HFR - Hôpital cantonal
Fribourg, Switzerland
Contact
-
Henry Dunant Hospital Center
Athens, Greece
Contact
-
Hospital General Universitario Alicante
Alicante, Spain
Contact
-
Hospital Universitatrio Puerta del Hierro
Madrid, Spain
Contact
-
Hospital Universitatrio Vall d'Hebron
Barcelona, Spain
Contact
-
Hospital de la Santa Creu I Sant Pau
Barcelona, Spain
Contact
-
Hôpital Nord de Marseille
Marseille, France
Contact
-
ICO Hospitalet H. Duran I Reynals / H. Bellvitge
Barcelona, Spain
Contact
-
Institut Bergonie
Bordeaux, France
Contact
-
Instituto Europeo di Oncologia (IEO)
Milan, Italy
Contact
-
Irccs Irst
Meldola, Italy
Contact
-
Istituto Nazionale Tumori "Regina Elena"
Roma, Italy
Contact
-
Kantonsspital Baden
Baden, Switzerland
Contact
-
Kantonsspital St.Gallen
Sankt Gallen, Switzerland
Contact
-
Lyon - Centre Léon Bérard
Lyon, France
Contact
-
Santa Maria della Misericordia Hospital
Perugia, Italy
Contact
Conditions
Explore the condition pages connected to this study.